Varenicline is a partial agonist of the alpha4beta2 neuronal nicotinic acetylcholine receptor (EC50 = 2.3 µM) and a full agonist at alpha7 neuronal nicotinic receptors.1 Clinically useful smoking cessation agent.2,3
* VAT and and shipping costs not included. Errors and price changes excepted